patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Re: CEO letter to shareholders. / High-Points
4
Sep 22, 2011 12:17PM
1
Sep 23, 2011 01:44PM

Ya... that quarterly with their chronology was rather depressing huh...

2.16

be able to buy more at 1.56 befor long

e

Share
New Message
Please login to post a reply